Steroidal Antiestrogen Fulvestrant Anti Cancer Drug WC Avai 129453-61-8
Contact Person : Jimmy Tian
Phone Number : 86-18602905046
WhatsApp : +8618602905046
Detail Information |
|||
Country Of Origin: | India | Form: | Injection |
---|---|---|---|
Storage Conditions: | Store At Room Temperature | Warnings: | Do Not Use In Pregnant Or Breastfeeding Women |
Contraindications: | Hypersensitivity To The Active Substance Or To Any Of The Excipients | Shelf Life: | 36 Months |
Indication: | Treatment Of Hormone Receptor-positive Metastatic Breast Cancer | Adverse Reactions: | Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia |
High Light: | Hormone Receptor Positive Metastatic Breast Fulvestrant,Injection Fulvestrant Powder,500mg Fulvestrant Pharmaceutical Intermediates |
Product Description
Fulvestrant, also known as Faslodex, is a type of hormone therapy developed by Pfizer, and manufactured in India. It is an injectable medication with a shelf life of 36 months. The active ingredient in Fulvestrant is a steroid hormone known as estradiol, which is used to treat certain types of breast cancer. It is typically used to treat postmenopausal women with hormone receptor-positive, metastatic breast cancer that has progressed despite treatment with other hormone therapies. It is not intended for use in pregnant or breastfeeding women, and should be used with caution in women with liver or kidney problems.
Faslodex is a fast-acting injection that works by blocking the action of estrogen, which can help slow or stop the growth of cancer cells. It is usually given as a single-dose injection every four weeks, and the cost of Faslodex can vary depending on the patient's insurance coverage. Common side effects of Faslodex include hot flashes, joint pain, fatigue, nausea, and headache. Patients should talk to their doctor if any of these side effects become severe or do not go away.
Attribute | Value |
---|---|
Administration | Intramuscular |
Country of Origin | India |
Shelf Life | 36 Months |
Product Name | Fulvestrant |
Strength | 500mg/5ml |
Manufacturer | Pfizer |
Storage Conditions | Store At Room Temperature |
Pack Size | 1 Vial |
Active Ingredient | Fulvestrant |
Adverse Reactions | Nausea, Vomiting, Fatigue, Headache, Hot Flashes, Bone Pain, Arthralgia, Myalgia, And Anorexia |
Fulvestrant, also known as Faslodex, is a fulvestrant injection manufactured by Pfizer. It is administered via intramuscular injection and has a shelf life of 36 months. The active ingredient, Fulvestrant, is indicated for the treatment of hormone receptor-positive metastatic breast cancer. It is an effective and reliable treatment option for individuals with this condition.
We offer a comprehensive range of technical support and services for Fulvestrant, including:
For more information on our technical support and services for Fulvestrant, please visit our website or contact us directly.
Enter Your Message